Johnson & Johnson announced the acquisition of Atraverse Medical, a privately held medical device company that develops left‑heart access and radiofrequency technologies. The deal adds Atraverse’s Hotwire Transseptal Access System—a guidewire and generator system used in nearly 3,000 clinical procedures worldwide—to J&J’s cardiovascular portfolio. While the transaction terms were not disclosed, the acquisition is expected to close in the second quarter of 2026 and aligns with J&J’s strategy to expand its high‑growth cardiac device segment.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.